scholarly journals The roles of predictors in cardiovascular risk models - a question of modeling culture?

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Christine Wallisch ◽  
Asan Agibetov ◽  
Daniela Dunkler ◽  
Maria Haller ◽  
Matthias Samwald ◽  
...  

Abstract Background While machine learning (ML) algorithms may predict cardiovascular outcomes more accurately than statistical models, their result is usually not representable by a transparent formula. Hence, it is often unclear how specific values of predictors lead to the predictions. We aimed to demonstrate with graphical tools how predictor-risk relations in cardiovascular risk prediction models fitted by ML algorithms and by statistical approaches may differ, and how sample size affects the stability of the estimated relations. Methods We reanalyzed data from a large registry of 1.5 million participants in a national health screening program. Three data analysts developed analytical strategies to predict cardiovascular events within 1 year from health screening. This was done for the full data set and with gradually reduced sample sizes, and each data analyst followed their favorite modeling approach. Predictor-risk relations were visualized by partial dependence and individual conditional expectation plots. Results When comparing the modeling algorithms, we found some similarities between these visualizations but also occasional divergence. The smaller the sample size, the more the predictor-risk relation depended on the modeling algorithm used, and also sampling variability played an increased role. Predictive performance was similar if the models were derived on the full data set, whereas smaller sample sizes favored simpler models. Conclusion Predictor-risk relations from ML models may differ from those obtained by statistical models, even with large sample sizes. Hence, predictors may assume different roles in risk prediction models. As long as sample size is sufficient, predictive accuracy is not largely affected by the choice of algorithm.

2014 ◽  
Vol 2014 ◽  
pp. 1-8 ◽  
Author(s):  
Elke E. A. Arts ◽  
Calin D. Popa ◽  
Jacqueline P. Smith ◽  
Onno J. Arntz ◽  
Fons A. van de Loo ◽  
...  

Objective. There is an unmet need for a specific cardiovascular risk (CV) algorithm for rheumatoid arthritis (RA) patients. Lipoprotein data are often not available in RA cohorts but could be obtained from frozen blood samples. The objective of this study was to estimate the storage effect on lipoproteins in long-term (>10 years) frozen serum samples.Methods. Data were used from an inception RA cohort. Multiple serum samples from 152 patients were analyzed for lipoproteins, being frozen for 1–26 years at −20°C. Storage effect on lipoproteins was estimated using longitudinal regression analyses and a lipid decay correction factor was developed. Clinical impact of the storage effect on lipoproteins was assessed by calculating the number of patients reclassified to another CV risk group according to the SCORE risk calculator after applying the decay correction factor.Results. There was a significant effect of storage time on total cholesterol (TC) (P< 0.001) and high density lipoprotein cholesterol (HDL-c) levels (P< 0.001), not LDL-c (P= 0.83). The lipid decay correction factor was 0.03 mmol/L and 0.024 mmol/L per additional year of storage for TC and HDL-c, respectively. The TC : HDL ratio decreased after correction for storage effect. After correction, only 5% of patients were reclassified to another CV risk group.Conclusion. A modest storage decay effect on lipoproteins was found that is unlikely to significantly affect CV risk stratification. Serum samples that have been stored long-term (>10 years) can be used to obtain valid lipid levels for developing CV risk prediction models in RA cohorts, even without applying a decay correction factor.


Author(s):  
Angel A. García-Peña ◽  
Esther De-Vries ◽  
Jairo Aldana-Bitar ◽  
Edward Cáceres ◽  
Juan Botero ◽  
...  

2018 ◽  
Vol 3 (11) ◽  
pp. 1096 ◽  
Author(s):  
Lindsay R. Pool ◽  
Hongyan Ning ◽  
John Wilkins ◽  
Donald M. Lloyd-Jones ◽  
Norrina B. Allen

The Lancet ◽  
2017 ◽  
Vol 390 ◽  
pp. S40
Author(s):  
Benjamin J Gray ◽  
Jeffrey W Stephens ◽  
Michael Thomas ◽  
Sally P Williams ◽  
Christine A Davies ◽  
...  

2019 ◽  
Vol 210 (4) ◽  
pp. 161-167 ◽  
Author(s):  
Loai Albarqouni ◽  
Jennifer A Doust ◽  
Dianna Magliano ◽  
Elizabeth LM Barr ◽  
Jonathan E Shaw ◽  
...  

Diabetes Care ◽  
2006 ◽  
Vol 29 (8) ◽  
pp. 1860-1865 ◽  
Author(s):  
J. C. Zgibor ◽  
G. A. Piatt ◽  
K. Ruppert ◽  
T. J. Orchard ◽  
M. S. Roberts

Sign in / Sign up

Export Citation Format

Share Document